Impact of COVID-19 on business activities and earnings
First written in FY2020-Q1. 8 of 14 entries say "Restated". Latest entry: FY2023.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
51 other companies' latest entry also says "Mitigated".
- FY2023MitigatedAnnual report
「Novel coronavirus disease was classified as a Category V disease under Japan's Infectious Diseases Control Act in May 2023, and the economy entered a gradual recovery trend from the effects of the COVID-19 pandemic.」
The company describes the change in the legal classification of novel coronavirus disease and the economy's recovery trend, indicating that the disease's impact on business activities is easing. - FY2023-Q3MitigatedAnnual report
「During the first nine months of the current consolidated fiscal year, the Japanese economy was on a recovery trend as socioeconomic activity normalized following the easing of restrictions on movement and the lifting of entry restrictions related to novel coronavirus disease. However, concerns remain over the effects of soaring raw-material and energy prices, rising prices and the weaker yen, and the outlook for the domestic economy remains uncertain.」
The company states that socioeconomic activity has normalized as restrictions on movement were eased and entry restrictions were lifted. Meanwhile, uncertainty remains due to soaring raw-material and energy prices, rising prices and the weaker yen. - FY2023-Q2MitigatedAnnual report
「During the first six months of the current consolidated fiscal year, the Japanese economy was on a gradual recovery trend as the spread of novel coronavirus disease subsided and the effects of various policies and the easing of restrictions progressed.」
The company states that the spread of novel coronavirus disease has subsided and that the effects of policies and the easing of restrictions are progressing. - FY2023-Q1RestatedAnnual report
「We will continue to closely monitor the effects of novel coronavirus disease in Japan and overseas, but depending on how the situation develops, it may affect the business activities and earnings of our group.」
The company continues to disclose that novel coronavirus disease may affect business activities and the ability to secure earnings. - FY2022RestatedAnnual report
「During the current consolidated fiscal year, Japan's economy showed signs of a gradual recovery after the priority preventive measures were lifted, but uncertainty about the outlook continued due to the resurgence of COVID-19, surging resource and energy prices resulting from the situation between Russia and Ukraine, and the rapid depreciation of the yen.」
The company continues to disclose that novel coronavirus disease may affect business activities and the ability to secure earnings, together with the Russia-Ukraine situation and soaring resource prices, among other factors. - FY2022-Q3RestatedAnnual report
「We will continue to monitor the status of novel coronavirus disease infections in Japan and overseas and the impact on the global economy of Russia's invasion of Ukraine, among other factors. Depending on how the situation develops, these factors may affect the business activities and earnings of our group.」
The company continues to disclose that the impact of novel coronavirus disease and the invasion of Ukraine on the global economy may affect business activities and the ability to secure earnings. - FY2022-Q2RestatedAnnual report
「We will continue to monitor the status of novel coronavirus disease infections in Japan and overseas and the impact on the global economy of Russia's invasion of Ukraine, among other factors. Depending on how the situation develops, these factors may affect the business activities and earnings of our group.」
The company continues to disclose that novel coronavirus disease may affect business activities and the ability to secure earnings, and also describes the impact of the invasion of Ukraine on the global economy. - FY2022-Q1RestatedAnnual report
「We will continue to closely monitor the effects of the spread of novel coronavirus disease in Japan and overseas, but depending on how the situation develops, it may affect the business activities and earnings of our group.」
The company continues to disclose that novel coronavirus disease may affect business activities and the ability to secure earnings. - FY2021-Q3RestatedAnnual report
「During the first nine months of the current consolidated fiscal year, there were no new matters among those relating to the business and accounting conditions described in this quarterly report that could have a material effect on investors' decisions, nor were there any material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year. We will continue to closely monitor the effects of the spread of novel coronavirus disease in Japan and overseas, but depending on how the situation develops, it may affect the business activities and earnings of our group.」
The company states that there have been no material changes to its business and other risks, while continuing to disclose that the spread of novel coronavirus disease in Japan and overseas may affect business activities and the ability to secure earnings. - FY2021-Q2RestatedAnnual report
「During the first six months of the current consolidated fiscal year, there were no new matters among those relating to the business and accounting conditions described in this quarterly report that could have a material effect on investors' decisions, nor were there any material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year. We will continue to closely monitor the effects of the spread of novel coronavirus disease in Japan and overseas, but depending on how the situation develops, it may affect the business activities and earnings of our group.」
The company states that there have been no material changes to its business and other risks, while continuing to disclose that the spread of novel coronavirus disease in Japan and overseas may affect business activities and the ability to secure earnings. - FY2021-Q1RestatedAnnual report
「During the first three months of the current consolidated fiscal year, there were no new matters among those relating to the business and accounting conditions described in this quarterly report that could have a material effect on investors' decisions, nor were there any material changes to the "Business and Other Risks" described in the annual securities report for the previous fiscal year. We will continue to closely monitor the effects of the spread of novel coronavirus disease in Japan and overseas, but depending on how the situation develops, it may affect the business activities and earnings of our group.」
The company states that there have been no material changes to its business and other risks, while continuing to disclose that the spread of novel coronavirus disease in Japan and overseas may affect business activities and the ability to secure earnings. - FY2020-Q3MaterialisedAnnual report
「Although sales and marketing activities in China and elsewhere have been restricted due to the effects of novel coronavirus disease, we will continue to actively pursue overseas business expansion by developing production equipment and seedling technologies and researching agriculture-related markets, with a focus on our seedling business in China, to establish a new business foundation.」
Novel coronavirus disease has resulted in restrictions on sales and marketing activities in China and elsewhere. - FY2020-Q2MaterialisedAnnual report
「During the first six months of the current consolidated fiscal year, the spread of novel coronavirus disease did not affect net sales. However, expenses increased because measures were taken to prevent infection, including reviews of production and work arrangements and employment adjustments.」
In response to novel coronavirus disease, production and work arrangements were reviewed and employment adjustments were implemented, resulting in higher costs for preventive measures. Meanwhile, net sales were not affected during the quarter. - FY2020-Q1First statedAnnual report
「The novel coronavirus disease that emerged in China in December 2019 has spread worldwide, including in Japan. Depending on how the situation develops, it may affect the business activities and earnings of our group.」
The spread of novel coronavirus disease worldwide and in Japan is identified as a new risk that may affect business activities and the ability to secure earnings.